Latest Market News

Briscoe Group reports a slight sales decline in Q3 2025 but stabilizes gross profit margins and advances key strategic projects, positioning itself cautiously for the critical fourth quarter.

Sun Silver Limited’s latest re-assay results confirm near-surface antimony mineralisation at its Maverick Springs Project, reinforcing its potential as a critical minerals hub alongside silver and gold. This comes as JPMorgan’s landmark US$75 million investment in U.S. antimony projects signals growing strategic focus on domestic mineral security.

Warriedar Resources shareholders have overwhelmingly approved a scheme of arrangement for acquisition by Capricorn Metals, clearing a key hurdle ahead of final court approval and delisting.

Aeris Resources has completed an $80 million equity placement and launched a share purchase plan, strengthening its balance sheet and setting ambitious production targets for FY26. The company is also divesting non-core assets to focus on growth and exploration.

Finexia Financial Group Limited (ASX – FNX) has had its trading suspension lifted immediately following its public response to recent media speculation. The reinstatement marks a pivotal moment for the financial group’s market activity.

Finexia Financial Group has formally ended preliminary discussions with Salter Brothers regarding a potential reverse listing and is seeking immediate reinstatement of its ASX securities.

VGI Partners Global Investments Limited has announced an on-market buy-back of its ordinary shares, set to begin in late November 2025 and run for a full year. The buy-back offers a flexible approach without fixed volume limits or a set price, signaling a strategic capital management move.

hummgroup and The Abercrombie Group have mutually agreed to end discussions on an unsolicited acquisition proposal, with TAG withdrawing its offer that included a 35% premium. The Independent Board Committee now shifts focus to operational execution and shareholder value.

The GPT Group has reported robust occupancy and sales growth across its property portfolios for the September quarter 2025, prompting an upgrade to its full-year earnings guidance.

Proteomics International secures half a million dollars from the Western Australian Government to accelerate commercialisation of PromarkerEndo, a groundbreaking blood test for early endometriosis diagnosis.

FSI’s FY2025 portfolio posted a modest 5.0% return, trailing the ASX All Ordinaries Index, while maintaining dividend growth and planning a strategic move into pre-IPO investments.

James Hardie Industries faces intense scrutiny from the ASX after its share price dropped sharply and trading volumes spiked, prompting urgent questions about undisclosed information.